Old Web
English
Sign In
Acemap
>
Paper
>
LBP-505 – Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe
LBP-505 – Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe
2017
Alison D. Marshall
Stine Nielsen
Evan B. Cunningham
A. Aghemo
Hannu Alho
Markus Backmund
Philip Bruggmann
Olav Dalgard
Robert Flisiak
Graham R. Foster
L. Gheorghe
David Goldberg
Ioannis Goulis
Matthew Hickman
P. Hoffmann
L. Jancorienė
Peter Jarčuška
Martin Kåberg
Mihály Makara
Matti Maimets
Rui Tato Marinho
Mojca Matičič
Suzanne Norris
S. Ólafsson
Anne Øvrehus
Jean-Michel Pawlotsky
James Pocock
Geert Robaeys
Carlos Roncero
M. Simonova
Jan Sperl
Michele Tait
Ieva Tolmane
S. Tomaselli
M. van der Valk
Adriana Vince
Gregory J. Dore
Jeffrey V. Lazarus
Jason Grebely
Keywords:
Virology
Reimbursement
Immunology
Interferon
Pharmacology
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]